Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

Also called NCT06710210

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06710210
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06710210. Randomized; single masking; primary purpose treatment. Start 2026-04-01 (actual); primary completion 2028-04-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease
Acronym
BIOHYBRID
Condition
Diffuse Coronary Artery Disease
Intervention (Device)
PCI with a bioresorbable scaffold and drug-coated balloon(s)
Intervention (Device)
PCI with drug-eluting stent(s)
Lead sponsor
University Hospital, Geneva (class: other)
Collaborator
Clinical Trials Unit Bern (CTU) (class: not stated)

Record details

Record id
cardio:ct-nct06710210
Content hash
d4f0861b41093e4dc5af933008efb43dac87f11ad9df2bbeb35f2dc9b9ef0cd2